Data Report

SUMMARY - The Food and Drug Administration (FDA) in the United States has revoked the emergency use authorization for four COVID-19 antibody-based drugs: bebtelovimab, Evusheld, sotrovimab & REGEN-COV. The reasons for the revocations are that the shelf life of those drugs had expired and that the drugs are not effective against the strains of Covid-19 currently circulating. There are no plans by the companies who make those drugs to re-apply for emergency use authorizations in the United States.

LINK - https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-revokes-authorization-five-covid-treatments-2024-12-23/